A paradoxical role in NSCLC has been attributed to TGF-β, because it acts as a tumor suppressor in early-stage tumors, but promotes tumor progression and metastasis in later stages (Zhang et al. 2014). The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.